Luke Anderton
About Luke Anderton
Luke Anderton is a Clinical Account Executive at Biosense Webster with extensive experience in sales consulting and management. He has worked in various roles within the company since 2017 and has a background in customer service and training.
Current Role at BioSense Webster
Luke Anderton currently serves as a Clinical Account Executive at BioSense Webster, a position he has held since 2021. He operates from Tampa Bay and is responsible for managing clinical accounts and enhancing customer relations. In addition to this role, he also works as a Field Trainer, a position he has maintained since 2019 in Sacramento, California. His responsibilities include training new staff and developing strategies to improve team performance.
Previous Experience at BioSense Webster
Luke Anderton has extensive experience at BioSense Webster, where he worked in various capacities. He served as a Clinical Account Specialist from 2017 to 2021 in Sacramento, California. In 2020, he took on the role of Interim Sales Manager for eight months. Additionally, he started as an Associate Clinical Account Specialist in 2017 for seven months, contributing to the company's sales and clinical operations.
Sales and Management Experience
Luke Anderton possesses over three years of experience in sales consulting, management, marketing, and customer service relations. His career includes roles such as Impact Manager at Abercrombie & Fitch and Sales and Marketing Manager at LA Fitness. He also worked as a Sales Consultant and Field Security Adviser at DEFENDER from 2013 to 2016, where he developed skills in sales strategy and customer engagement.
Educational Background
Luke Anderton has a diverse educational background. He studied at Mansfield University of Pennsylvania, where he earned a Bachelor of Science in Criminal Justice/Law Enforcement Administration from 2007 to 2011. He also attended Volgograd State University, focusing on General Studies with an emphasis on Russian Culture in 2010. Additionally, he studied at the Arrhythmia Technologies Institute, achieving expertise in Medical Devices and Cardiac Rhythm Management from 2016 to 2017.